Peng Cheng

4PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 08, 2025
Profiling with senescence-associated secretory phenotype score identifies GDC-0879 as a small molecule sensitizing glioblastoma to anti-PD1.

Yang Liu, Yuan Feng, Lin Cheng

|Jan 22, 2025
Targeting ARPC1B Overcomes Immune Checkpoint Inhibitor Resistance in Glioblastoma by Reversing Protumorigenic Macrophage Polarization.

Tianqi Liu, Tao Sun, Xin Chen

|Oct 01, 2024
Hexosaminidase B-driven cancer cell-macrophage co-dependency promotes glycolysis addiction and tumorigenesis in glioblastoma.

Chen Zhu, Xin Chen, Tian-Qi Liu

|Dec 19, 2023
Tumor microenvironment remodeling plus immunotherapy could be used in mesenchymal-like tumor with high tumor residual and drug resistant rate.

Shuai Shen, Xing Liu, Qing Guo

Pageof 1

Frequent Collaborators

4 joint publications

Anhua Wu

3 joint publications

Wen Cheng

2 joint publications

Xin Chen

1 joint publications

Shuai Shen